⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL8899403 | 0.82 | TSHR (0.33) | — | |
| Dioxane SCHEMBL4888055 | 0.79 | TTR (0.38) | — | |
| SCHEMBL13644289 | 0.79 | — | — | |
| SCHEMBL13916843 | 0.79 | — | — | |
| SCHEMBL6919 | 0.78 | — | — | |
| SCHEMBL4442942 | 0.78 | — | — | |
| Propylene Glycol SCHEMBL8899682 | 0.74 | TDP1 (0.56) | — | |
| SCHEMBL2846539 | 0.71 | — | — | |
| SCHEMBL17789953 | 0.71 | — | — | |
| SCHEMBL28143 | 0.71 | THRB (0.59) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1316 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122037167-A | Preparation method of double-end hydroxyl oligomeric polyphenyl ether | 中南大学 | 2026-05-15 | — | — | CN | claimed |
| CN-117683052-A | Preparation method of KRAS G12D inhibitor MRTX1133 | 上海相辉医药科技有限公司 | 2024-03-12 | — | — | CN | claimed |
| CN-115322198-A | Pharmaceutical compound based on quinolizidine derivatives and preparation method and application thereof | 上海工程技术大学 | 2022-11-11 | — | — | CN | claimed |
| US-20200225218-A1 | Nanoparticle Aggregates | Ellume Limited (AU) | 2020-07-16 | — | — | US | claimed |
| US-20160264530-A1 | NALPHA, NALPHA, NALPHA-TRIALKYL HISTIDINE DERIVATIVES USEFUL FOR THE PREPARATION OF ERGOTHIONEINE COMPOUNDS | MIRONOVA INNOVATIONS, LLC | 2016-09-15 | — | — | US | claimed |
| US-9428463-B1 | Nα, Nα, Nα-trialkyl histidine derivatives useful for the preparation of ergothioneine compounds | MIRONOVA INNOVATIONS, LLC (US) | 2016-08-30 | — | — | US | claimed |
| EP-1650212-B1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT, PROCESS FOR PRODUCING THE SAME, AND PROCESS FOR PRODUCING OPTICALLY ACTIVE ALPHA-AMINO ACID DERIVATIVE WITH THE SAME | TOSOH CORP (JP) | 2012-11-14 | — | — | EP | claimed |
| US-20070270484-A1 | 3'-N-Substituted-3-O-Substituted Erythronolide a Derivatives | RANBAXY LABORATORIES LIMITED (IN) | 2007-11-22 | — | — | US | claimed |
| WO-2005030786-A1 | 3'-N-SUBSTITUTED-3-O-SUBSTITUTED ERYTHRONOLIDE A DERIVATIVES | RANBAXY LABORATORIES LIMITED (US) | 2005-04-07 | — | — | WO | claimed |
| EP-0922050-B1 | 3-DESCLADINOSE-2,3-ANHYDROERYTHROMYCIN DERIVATIVES | ABBOTT LAB (US) | 2003-07-30 | — | — | EP | claimed |
| EP-0922050-A1 | 3-DESCLADINOSE-2,3-ANHYDROERYTHROMYCIN DERIVATIVES | ABBOTT LABORATORIES (US) | 1999-06-16 | — | — | EP | claimed |
| US-5750510-A | ANTIBIOTICS | ABBOTT LABORATORIES (US) | 1998-05-12 | — | — | US | claimed |
| WO-1997042205-A1 | 3-DESCLADINOSE-2,3-ANHYDROERYTHROMYCIN DERIVATIVES | ABBOTT LABORATORIES (US) | 1997-11-13 | — | — | WO | claimed |
| JP-5222089-A | — | — | None | — | — | JP | disclosed |
| US-20260146039-A1 | NEUROPLASTIGEN MODULATORS FOR THE TREATMENT OF PAIN, ITCH AND NERVE INJURY | CACTI, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| CN-122094944-A | Preparation of oxadiazolyl amino benzobises method for preparing azepine derivatives | — | 2026-05-26 | — | — | CN | disclosed |
| EP-0312087-A2 | Amides of bis-aldonic acids and a method for their preparation | LUITPOLD PHARMA GmbH (DE) | 1989-04-19 | — | — | EP | disclosed |
| US-4717721-A | LEUKEMIA | HOWARD W. BREMER (US) | 1988-01-05 | — | — | US | disclosed |
| EP-0197949-A1 | VITAMIN D DERIVATIVES AND METHODS FOR PREPARING SAME | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1986-10-22 | — | — | EP | disclosed |
| WO-1986002078-A1 | VITAMIN D DERIVATIVES AND METHODS FOR PREPARING SAME | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1986-04-10 | — | — | WO | disclosed |